News
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
is pending final approval by the director of the CDC and the Department of Health and Human Services. Pfizer currently is the only company with an RSV vaccine to help protect adults aged 60 ...
Pfizer (PFE) announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand ...
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results